These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23857699)

  • 1. Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis.
    Marson FA; Bertuzzo CS; Ribeiro MÂ; Ribeiro AF; Ribeiro JD
    J Bras Pneumol; 2013; 39(3):306-16. PubMed ID: 23857699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator mutations at a referral center for cystic fibrosis.
    Coutinho CA; Marson FA; Ribeiro AF; Ribeiro JD; Bertuzzo CS
    J Bras Pneumol; 2013; 39(5):555-61. PubMed ID: 24310628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
    Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
    PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
    Sawicki GS; Van Brunt K; Booth J; Bailey E; Millar SJ; Konstan MW; Flume PA
    J Cyst Fibros; 2022 Jan; 21(1):96-103. PubMed ID: 34289939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene.
    Dupuis A; Keenan K; Ooi CY; Dorfman R; Sontag MK; Naehrlich L; Castellani C; Strug LJ; Rommens JM; Gonska T
    Genet Med; 2016 Apr; 18(4):333-40. PubMed ID: 26087176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
    Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
    Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-to-date and projected estimates of survival for people with cystic fibrosis using baseline characteristics: A longitudinal study using UK patient registry data.
    Keogh RH; Szczesniak R; Taylor-Robinson D; Bilton D
    J Cyst Fibros; 2018 Mar; 17(2):218-227. PubMed ID: 29311001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection Dynamics of Aspergillus fumigatus in Adults with Cystic Fibrosis (CF).
    Moore JE; Rendall JC; Millar BC
    Mycopathologia; 2023 Oct; 188(5):699-704. PubMed ID: 37012557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.
    Thauvin-Robinet C; Munck A; Huet F; Génin E; Bellis G; Gautier E; Audrézet MP; Férec C; Lalau G; Georges MD; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Costa C; Medina R; Leclerc J; Hubert D; Nové-Josserand R; Sermet-Gaudelus I; Rault G; Flori J; Leroy S; Wizla N; Bellon G; Haloun A; Perez-Martin S; d'Acremont G; Corvol H; Clément A; Houssin E; Binquet C; Bonithon-Kopp C; Alberti-Boulmé C; Morris MA; Faivre L; Goossens M; Roussey M; ; Girodon E
    J Med Genet; 2009 Nov; 46(11):752-8. PubMed ID: 19880712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Presentation of the c.3844T>C (p.Trp1282Arg, W1282R) Variant in Russian Cystic Fibrosis Patients.
    Petrova NV; Kashirskaya NY; Krasovskiy SA; Amelina EL; Kondratyeva EI; Marakhonov AV; Vasilyeva TA; Voronkova AY; Sherman VD; Ginter EK; Kutsev SI; Zinchenko RA
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 32992607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients.
    Decaestecker K; Decaestecker E; Castellani C; Jaspers M; Cuppens H; De Boeck K
    Eur Respir J; 2004 May; 23(5):679-84. PubMed ID: 15176679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.
    Chaima S; Sondess HF; Khedija B; Ahmed M; Taieb M
    Ann Biol Clin (Paris); 2020 Jun; 78(3):314-318. PubMed ID: 32540817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation.
    Mondejar-Lopez P; Zolin A; Garcia-Marcos PW; Pastor-Vivero MD; Rosa-Silvestre M; de Asis Sanchez-Martinez F; Salvatore D; Cimino G; Majo F; Sole-Jover A; Asensio de la Cruz O; Calderazzo MA; Pizzamiglio G; Castillo-Corullon S; Alvarez-Fernandez A; Gartner S; Padoan R; Carnovale V; Salvatore M; Moya-Quiles MR; Orenti A; Glover G; Sanchez-Solis M
    Respir Med; 2022 Feb; 192():106736. PubMed ID: 35032736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
    Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
    J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
    Ren CL; Desai H; Platt M; Dixon M
    Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic, clinical, and laboratory parameters of cystic fibrosis during the last two decades: a comparative analysis.
    Marson FA; Hortencio TD; Aguiar KC; Ribeiro JD;
    BMC Pulm Med; 2015 Jan; 15():3. PubMed ID: 25592785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
    Siryani I; Jama M; Rumman N; Marzouqa H; Kannan M; Lyon E; Hindiyeh M
    PLoS One; 2015; 10(7):e0133890. PubMed ID: 26208274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with cystic fibrosis having a residual function mutation: Data from the Italian registry.
    Salvatore D; Padoan R; Buzzetti R; Amato A; Giordani B; Ferrari G; Majo F
    Pediatr Pulmonol; 2019 Feb; 54(2):150-157. PubMed ID: 30561903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of cystic fibrosis patients with the G551D mutation.
    Comer DM; Ennis M; McDowell C; Beattie D; Rendall J; Hall V; Elborn JS
    QJM; 2009 Nov; 102(11):793-8. PubMed ID: 19734299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.